Epilepsy management

Postgraduate Medicine

Volumn 102, Issue 1, 1997, Pages 102-122

  Sperling, Michael R ^a   Bucurescu, Gabriel ^a   Kim, Brian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; BRAIN SURGERY; CONFERENCE PAPER; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; FOCAL EPILEPSY; GRAND MAL EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; MEDICAL DECISION MAKING; TREATMENT PLANNING; ARTICLE; BRAIN; ELECTROENCEPHALOGRAPHY; EPILEPSY; RECURRENT DISEASE; RISK FACTOR; TREATMENT FAILURE;

ANTICONVULSANTS; BRAIN; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; RECURRENCE; RISK FACTORS; TREATMENT FAILURE;

EID: 0031179197     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.07.251     Document Type: Conference Paper

References (32)

1. Gowers WR. Epilepsy and other chronic convulsive diseases: their causes, symptoms, and treatment. New York: Wood, 1885:255
2. Herzog AG. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia 1991;32(Suppl 6): S27-33
3. Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988;38(3):432-4
4. Mattson RH, Cramer JA, Caldwell BV, et al. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984;34(9):1255-8
5. Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986;36(12):1607-10
6. Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995;45(9):1660-2
7. Rosenfeld WE, Doose DR, Walker SA, et al. Effects of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997;38(3):317-23
8. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. Contraception 1986;33(6):559-65
9. Christianson SA, Silfvenius H, Saisa J, et al. Life satisfaction and sexuality in patients operated for epilepsy. Acta Neurol Scand 1995;92(1):1-6
10. Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia 1994;35(4):750-6
11. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia 1995;36(4):355-9
12. Kalter H, Warkany J. Congenital malformations (second of two parts). N Engl J Med 1983;308(9):491-7
13. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42(4 Suppl 5):149-60
14. Minkoff H, Schaffer RM, Delke I, et al. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol 1985;65(Suppl 3):22-4S
15. Yerby MS. Problems and management of the pregnant woman with epilepsy. Epilepsia 1987;28(Suppl 3):S29-36
16. Hanson JW, Myrianthopoulos NC, Harvey MA, et al. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976;89(4):662-8
17. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324(10):674-7
18. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. (Letter) Lancet 1982;2(8304):937
19. Omtzigt JG, Los FJ, Grobbee DE, et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 1992;42(4 Suppl 5):119-25
20. Lamotrigine pregnancy registry: interim report. Research Triangle Park, NC: GlaxoWellcome Inc, March 1996
21. Kaneko S, Otani K, Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988; 29(4):459-67
22. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338(8760):131-7
23. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269(10):1257-61
24. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327(26):1832-5
25. Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992; 42(4 Suppl 5):32-42
26. Yerby MS, Friel PN, McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992;42(4 Suppl 5):12-6
27. Luthy DA, Wardinsky T, Shurtleff DB, et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med 1991;324(10):662-6
28. Yerby MS. Problems and management of the pregnant woman with epilepsy. Epilepsia 1987;28(Suppl 3):S29-36
29. Yerby MS. Pregnancy and epilepsy. Epilepsia 1991;32(Suppl 6): S51-9
30. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 1993;34(4):588-9
31. Rosciszewska D. Epilepsy and menstruation. In: Hopkins A, ed. Epilepsy. London: Chapman & Hall, 1987
32. Abbasi F, Krumholz A, Kittner S, et al. Effects of menopause on women with epilepsy. (Abstr) Epilepsia 1995;36(Suppl 4):148